Day One Biopharmaceuticals
DAWN
DAWN
139 hedge funds and large institutions have $1.12B invested in Day One Biopharmaceuticals in 2023 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
18% more capital invested
Capital invested by funds: $952M → $1.12B (+$171M)
7% more funds holding
Funds holding: 130 → 139 (+9)
0.81% less ownership
Funds ownership: 89.17% → 88.36% (-0.81%)
Holders
139
Holding in Top 10
4
Calls
$1.66M
Puts
$575K
Top Buyers
| 1 | +$28.8M | |
| 2 | +$12.8M | |
| 3 | +$7.64M | |
| 4 |
Morgan Stanley
New York
|
+$7.45M |
| 5 |
B
Braidwell
Stamford,
Connecticut
|
+$7.3M |
Top Sellers
| 1 | -$30.6M | |
| 2 | -$30M | |
| 3 | -$27.5M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$13.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$12.9M |